Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
Ana Matošević, Anamarija Knežević, Antonio Zandona, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1220-1220
Open Access | Times Cited: 10

Showing 10 citing articles:

New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 8
Resveratrol-Based Carbamates as Selective Butyrylcholinesterase Inhibitors: Design, Synthesis, Computational Study and Biometal Complexation Capability
Mario Sviben, Ilijana Odak, Danijela Barić, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 316-316
Open Access
Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease
Ana Matošević, Dejan Opsenica, Marta Spasić, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110620-110620
Closed Access | Times Cited: 11
Evaluation of Anticholinesterase Activity of the Fungicides Mefentrifluconazole and Pyraclostrobin
Dora Kolić, Goran Šinko
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6310-6310
Open Access | Times Cited: 2
Drug Candidates for the Treatment of Alzheimer’s Disease: New Findings from 2021 and 2022
Sujatha L. Motebennur, B. P. Nandeshwarappa, Manjunatha S. Katagi
Drugs and Drug Candidates (2023) Vol. 2, Iss. 3, pp. 571-590
Open Access | Times Cited: 5
New Heterostilbene and Triazole Oximes as Potential CNS-Active and Cholinesterase-Targeted Therapeutics
Milena Mlakić, Tena Čadež, Goran Šinko, et al.
(2024)
Open Access | Times Cited: 1
Synthesis, biological evaluation, molecular docking, and MD simulation of novel 2,4-disubstituted quinazoline derivatives as selective butyrylcholinesterase inhibitors and antioxidant agents
Sara Sadeghian, Raziyeh Razmi, Soghra Khabnadideh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Novel Inhibitors of Acetyl- and Butyrylcholinesterase Derived from Benzohydrazides: Synthesis, Evaluation and Docking Study
Neto-Honorius Houngbedji, Šárka Štěpánková, Václav Pflégr, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 172-172
Open Access | Times Cited: 2
New Heterostilbene and Triazole Oximes as Potential CNS-Active and Cholinesterase-Targeted Therapeutics
Milena Mlakić, Tena Čadež, Goran Šinko, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 679-679
Open Access
Evaluation of hydrazone and N -acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer’s disease
Marija Bartolić, Ana Matošević, Nikola Maraković, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Page 1

Scroll to top